<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7356537\results\search\drug\results.xml">
  <result pre="deliver medical interventions in the pre-hospital or in-hospital setting [70]." exact="Prompt" post="activation of emergency medical services (EMS) is crucial, since"/>
  <result pre="ACS patients, care should be taken when administering antiplatelet therapy." exact="Clopidogrel" post="and ticagrelor have specific interactions with lopinavirâ€&quot;ritonavir, a combination"/>
  <result pre="care should be taken when administering antiplatelet therapy. Clopidogrel and" exact="ticagrelor" post="have specific interactions with lopinavirâ€&quot;ritonavir, a combination of antiviral"/>
  <result pre="benefit [99]. Lopinavirâ€&quot;ritonavir should not be used in combination with" exact="clopidogrel" post="or ticagrelor due to their potent CYP3A4 inhibition [100],"/>
  <result pre="Lopinavirâ€&quot;ritonavir should not be used in combination with clopidogrel or" exact="ticagrelor" post="due to their potent CYP3A4 inhibition [100], which results"/>
  <result pre="CYP3A4 inhibition [100], which results in a diminished effect of" exact="clopidogrel" post="and an increased effect of ticagrelor; prasugrel should be"/>
  <result pre="utilization, or quality of life in patients with Covid-19 using" exact="aspirin" post="and other non-steroidal anti-inflammatory drugs (NSAIDS) has been provided,"/>
  <result pre="by the WHO [103]. It may be assumed that low-dose" exact="aspirin" post="can be safely used as antiplatelet drug in Covid-19"/>
  <result pre="be safely used as antiplatelet drug in Covid-19 patients. Additionally," exact="atorvastatin" post="and rosuvastatin should be started at the lowest possible"/>
  <result pre="statins [101]. Beta-blockersâ€&quot;especially metoprololâ€&quot;should be administered cautiously in patients consuming" exact="chloroquine" post="or hydroxychloroquine due to CYP2D6 inhibition [104] and the"/>
  <result pre="Beta-blockersâ€&quot;especially metoprololâ€&quot;should be administered cautiously in patients consuming chloroquine or" exact="hydroxychloroquine" post="due to CYP2D6 inhibition [104] and the potential role"/>
  <result pre="due to CYP2D6 inhibition [104] and the potential role of" exact="hydroxychloroquine" post="in reducing heart rate [105]. Reninâ€&quot;angiotensinâ€&quot;aldosterone system (RAAS)-related drugs"/>
  <result pre="case reports have highlighted the necessity of augmented doses of" exact="warfarin" post="in patients treated with ribavirin; the international normalized ratio"/>
  <result pre="is involved in the hepatic clearance of some novel OACs," exact="rivaroxaban" post="should be avoided and apixaban should be administered at"/>
  <result pre="clearance of some novel OACs, rivaroxaban should be avoided and" exact="apixaban" post="should be administered at 50% of the standard dose"/>
  <result pre="SARS: Initial virological and clinical findingsThorax200410.1136/thorax.2003.01265814985565 98.KimU.J.WonE.J.KeeS.J.JungS.I.JangH.C.Combination therapy with lopinavir/ritonavir," exact="ribavirin" post="and interferon-a for Middle East respiratory syndromeAntivir. Ther.20162145545910.3851/IMP300226492219 99.CaoB.WangY.WenD.LiuW.WangJ.FanG.RuanL.SongB.CaiY.WeiM.et"/>
  <result pre="with severe covid-19N. Engl. J. Med.202010.1056/NEJMoa200128232187464 100.DuangchaemkarnK.ReisfeldB.LohitnavyM.A pharmacokinetic model of" exact="lopinavir" post="in combination with ritonavir in humanProceedings of the 36th"/>
  <result pre="J. Med.202010.1056/NEJMoa200128232187464 100.DuangchaemkarnK.ReisfeldB.LohitnavyM.A pharmacokinetic model of lopinavir in combination with" exact="ritonavir" post="in humanProceedings of the 36th Annual International Conference of"/>
  <result pre="with COVID-19Available online: https://www.who.int/news-room/commentaries/detail/the-use-of-non-steroidal-anti-inflammatory-drugs-(nsaids)-in-patients-with-covid-19(accessed on 18 May 2020) 104.SomerM.KallioJ.PesonenU.PyykkÃ¶K.HuupponenR.ScheininM.Influence of" exact="hydroxychloroquine" post="on the bioavailability of oral metoprololBr. J. Clin. Pharmacol.200010.1046/j.1365-2125.2000.00197.x"/>
  <result pre="treatments for coronavirus disease 2019 (COVID-19): A reviewJAMA202010.1001/jama.2020.6019 109.PetersonD.Van ErmenA.Increased" exact="warfarin" post="requirements in a patient with chronic hepatitis C infection"/>
  <result pre="requirements in a patient with chronic hepatitis C infection receiving" exact="sofosbuvir" post="and ribavirinAm. J. Health Pharm.20177488889210.2146/ajhp16073028596225 110.PuglisiG.M.SmithS.M.JankovichR.D.AshbyC.R.JodlowskiT.Z.Paritaprevir/ritonavir/ombitasvir+dasabuvir plus ribavirin therapy"/>
  <result pre="infection receiving sofosbuvir and ribavirinAm. J. Health Pharm.20177488889210.2146/ajhp16073028596225 110.PuglisiG.M.SmithS.M.JankovichR.D.AshbyC.R.JodlowskiT.Z.Paritaprevir/ritonavir/ombitasvir+dasabuvir plus" exact="ribavirin" post="therapy and inhibition of the anticoagulant effect of warfarin:"/>
  <result pre="coadministered with lopinavirâ€&quot;ritonavir, diminished effect of clopidogrel, increased effect of" exact="ticagrelor" post="[101]. Consider using prasugrel if no contraindications [101].Contraindications to"/>
  <result pre="[112].Contraindications for ticagrelor: previous intracranial hemorrhage or ongoing bleeds [112]." exact="Aspirin" post="- Lack of evidence on discontinuation of aspirin in"/>
  <result pre="bleeds [112]. Aspirin - Lack of evidence on discontinuation of" exact="aspirin" post="in Covid-19 patients. Low-dose aspirin can be assumed to"/>
  <result pre="of evidence on discontinuation of aspirin in Covid-19 patients. Low-dose" exact="aspirin" post="can be assumed to be safe as antiplatelet drug"/>
  <result pre="-Lovastatin -Simvastatin Lopinavirâ€&quot;Ritonavir When coadministered with lopinavirâ€&quot;ritonavir, increased effect of" exact="atorvastatin" post="and rosuvastatin [101]. Start at lowest possible dose of"/>
  <result pre="rosuvastatin [101]. Start at lowest possible dose of rosuvastatin and" exact="atorvastatin" post="and titrate, otherwise use pravastatin [101]. Beta-blockers: -Metoprolol -Carvedilol"/>
  <result pre="possible dose of rosuvastatin and atorvastatin and titrate, otherwise use" exact="pravastatin" post="[101]. Beta-blockers: -Metoprolol -Carvedilol -Propranolol -Labetalol Chloroquineâ€&quot;Hydroxychloroquine Fingolimod Hydroxychloroquine"/>
  <result pre="use pravastatin [101]. Beta-blockers: -Metoprolol -Carvedilol -Propranolol -Labetalol Chloroquineâ€&quot;Hydroxychloroquine Fingolimod" exact="Hydroxychloroquine" post="has a potential role in reducing heart rate and"/>
  <result pre="and may increase effect of beta-blockers [105]. When coadministered with" exact="chloroquine" post="or hydroxychloroquine, beta-blockers dose reduction may be required [105]."/>
 </snippets>
</snippetsTree>
